Natco Pharma: Focusing On Complex Products

An opportunity to average out lower as per me :grinning_face:

Natco has been persuing geographical diversification to build a base business to insure earnings from volatile, higk risk, high reward and perhaps now fickle US business.

Initial forays into Canada, Brazil though subs building on its R&D developed for US business have borne decent results.

Now they are looking at Africa acquiring stake in Adcock. Benefits would be 2 fold. One augmentation of earnings through stake and in the medium term African market for existing products. That would take time due to registration process. Another acquisition in Latam or Europe could be in the offing.

Patience in Natco counter us bound to rewarded.

1 Like

Letter of Rights issue has been approved by board and ISIN obtained for listing of RE at NSE. Priced at Rs. 750

What’s concerning is that the promoters haven’t declared anything about their participation in the rights issue.

Isn’t mandatory for the promoters to announce if they are not subscribe to the rights issue.

But it’s mandatory to announce their participation in rights and since they haven’t said anything by inverse theres a good chance that they don’t pick up their rights.

Actually, very concerning. The reason I am being invested in Natco is that I am able to relate to their moon shot ventures but lack of skin in the game is an antithesis to their philosophy. After QIP and rights promotor holding would dip to 39.6% from 49.41%